NEW YORK (GenomeWeb) – Molecular diagnostics firms Biocept and Insight Genetics today announced that they will collaborate on the development of a test designed to detect the expression and mutation of ALK, a gene involved in signal transduction and a therapeutic target for non-small cell lung cancer.